The mRNA-Binding Protein IGF2BP1 Restores Fetal Hemoglobin in Cultured Erythroid Cells from Patients with β-Hemoglobin Disorders

[1]  C. von Kalle,et al.  Gene Therapy in Patients with Transfusion‐Dependent β‐Thalassemia , 2018, The New England journal of medicine.

[2]  S. Orkin,et al.  14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblasts , 2018, Human molecular genetics.

[3]  J. D. Engel,et al.  Fetal Hemoglobin Induction by Epigenetic Drugs. , 2018, Seminars in hematology.

[4]  S. Orkin,et al.  Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies , 2018, British journal of haematology.

[5]  R. Proia,et al.  IGF2BP1 overexpression causes fetal-like hemoglobin expression patterns in cultured human adult erythroblasts , 2017, Proceedings of the National Academy of Sciences.

[6]  A. Miccio,et al.  Gene Therapy for β-Hemoglobinopathies. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  G. Veres,et al.  Gene Therapy in a Patient with Sickle Cell Disease: Brief Report , 2017, The New England journal of medicine.

[8]  Matthew C. Canver,et al.  Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype. , 2016, The Journal of clinical investigation.

[9]  Gene W. Yeo,et al.  Enhanced CLIP Uncovers IMP Protein-RNA Targets in Human Pluripotent Stem Cells Important for Cell Adhesion and Survival. , 2016, Cell reports.

[10]  T. Lu,et al.  Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  W. Gu,et al.  IMP1 suppresses breast tumor growth and metastasis through the regulation of its target mRNAs , 2016, Oncotarget.

[12]  S. Borwornpinyo,et al.  Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the βA(T87Q)-Globin Gene , 2016, Human gene therapy.

[13]  Matthew C. Canver,et al.  Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin , 2016, Science.

[14]  M. Weiss,et al.  Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells , 2015, Molecular therapy. Methods & clinical development.

[15]  M. Steinberg,et al.  HbA2: biology, clinical relevance and a possible target for ameliorating sickle cell disease , 2015, British journal of haematology.

[16]  Y. T. Lee,et al.  Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping. , 2015, Blood.

[17]  M. Walters.  Update of hematopoietic cell transplantation for sickle cell disease , 2015, Current opinion in hematology.

[18]  Michael L Kaufman,et al.  Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells. , 2015, Experimental hematology.

[19]  D. Weatherall,et al.  The α-thalassemias. , 2014, The New England journal of medicine.

[20]  M. Testi,et al.  Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach. , 2013, Blood.

[21]  Michael L Kaufman,et al.  β-globin gene transfer to human bone marrow for sickle cell disease. , 2013, The Journal of clinical investigation.

[22]  Stefan Hüttelmaier,et al.  Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? , 2012, Cellular and Molecular Life Sciences.

[23]  Luca Pinello,et al.  Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis. , 2012, Developmental cell.

[24]  S. Rivella,et al.  Therapeutic Hemoglobin Levels after Gene Transfer in β-Thalassemia Mice and in Hematopoietic Cells of β-Thalassemia and Sickle Cells Disease Patients , 2012, PloS one.

[25]  Ryan K. Dale,et al.  Distinct Ldb1/NLI complexes orchestrate γ-globin repression and reactivation through ETO2 in human adult erythroid cells. , 2011, Blood.

[26]  H. Park,et al.  High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice , 2011, PloS one.

[27]  S. Orkin,et al.  Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer. , 2011, Blood.

[28]  Jérôme Larghero,et al.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia , 2010, Nature.

[29]  G. Tonon,et al.  Correction of β-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients , 2010, EMBO molecular medicine.

[30]  C. Barbas,et al.  A zinc-finger transcriptional activator designed to interact with the gamma-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts. , 2010, Blood.

[31]  S. Orkin,et al.  Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6. , 2010, Genes & development.

[32]  Scott B. Dewell,et al.  Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP , 2010, Cell.

[33]  T. Hansen,et al.  IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. , 2009, Journal of molecular endocrinology.

[34]  N. Mahmud,et al.  Transcriptional activation of the gamma-globin gene in baboons treated with decitabine and in cultured erythroid progenitor cells involves different mechanisms. , 2009, Experimental hematology.

[35]  Stuart H. Orkin,et al.  Developmental and species-divergent globin switching are driven by BCL11A , 2009, Nature.

[36]  H. Meiselman,et al.  A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction. , 2009, Blood.

[37]  John T. Powers,et al.  Lin28 Enhances Tumorigenesis and is Associated With Advanced Human Malignancies , 2009, Nature Genetics.

[38]  S. Thein,et al.  Discovering the genetics underlying foetal haemoglobin production in adults , 2009, British journal of haematology.

[39]  J. Gray,et al.  Correction of Murine Sickle Cell Disease Using γ-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[40]  Chunhui Hou,et al.  CTCF-dependent enhancer-blocking by alternative chromatin loop formation , 2008, Proceedings of the National Academy of Sciences.

[41]  J. Hirschhorn,et al.  Supporting Online Material Materials and Methods Figs. S1 to S10 Tables S1 to S7 References Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-specific Repressor Bcl11a , 2022 .

[42]  J. Yee,et al.  Improved Human β-globin Expression from Self-inactivating Lentiviral Vectors Carrying the Chicken Hypersensitive Site-4 (cHS4) Insulator Element. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[43]  E. Moss,et al.  Heterochronic Genes and the Nature of Developmental Time , 2007, Current Biology.

[44]  A. Krogh,et al.  Molecular Composition of IMP1 Ribonucleoprotein Granules*S , 2007, Molecular & Cellular Proteomics.

[45]  L. Contu,et al.  Unrelated donor stem cell transplantation in adult patients with thalassemia , 2005, Bone Marrow Transplantation.

[46]  M. Andreani,et al.  Bone Marrow Transplantation in Adults with Thalassemia: Treatment and Long‐Term Follow‐Up , 2005, Annals of the New York Academy of Sciences.

[47]  G. Stamatoyannopoulos.  Control of globin gene expression during development and erythroid differentiation. , 2005, Experimental hematology.

[48]  J. Yisraeli.  VICKZ proteins: a multi‐talented family of regulatory RNA‐binding proteins , 2005, Biology of the cell.

[49]  Licheng Zeng,et al.  Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. , 2004, Blood.

[50]  D. Srivastava,et al.  Extended β-globin locus control region elements promote consistent therapeutic expression of a γ-globin lentiviral vector in murine β-thalassemia , 2004 .

[51]  T. Hansen,et al.  Dwarfism and Impaired Gut Development in Insulin-Like Growth Factor II mRNA-Binding Protein 1-Deficient Mice , 2004, Molecular and Cellular Biology.

[52]  D. Levasseur,et al.  Correction of a mouse model of sickle cell disease: lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells. , 2003, Blood.

[53]  S. Rivella,et al.  A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer. , 2003, Blood.

[54]  A. Nienhuis,et al.  The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number. , 2003, Blood.

[55]  Erik Splinter,et al.  Looping and interaction between hypersensitive sites in the active beta-globin locus. , 2002, Molecular cell.

[56]  R. Nagel,et al.  Permanent and panerythroid correction of murine β thalassemia by multiple lentiviral integration in hematopoietic stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Rivella,et al.  Successful treatment of murine β-thalassemia intermedia by transfer of the human β-globin gene , 2002 .

[58]  Jody A. Vandergriff,et al.  Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[59]  R. Nagel,et al.  Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy , 2001, Science.

[60]  S. Lukyanov,et al.  Fluorescent proteins from nonbioluminescent Anthozoa species , 1999, Nature Biotechnology.

[61]  F. Nielsen,et al.  A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development , 1999, Molecular and Cellular Biology.

[62]  H. Bunn.  Pathogenesis and treatment of sickle cell disease. , 1997, The New England journal of medicine.

[63]  Michael L Kaufman,et al.  b-globin gene transfer to human bone marrow for sickle cell disease , 2018 .

[64]  Chao‐Ping Yang,et al.  Transplantation of unrelated donor umbilical cord blood for nonmalignant diseases: a single institution's experience with 45 patients. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[65]  M. Walters.  Stem cell therapy for sickle cell disease: transplantation and gene therapy. , 2005, Hematology. American Society of Hematology. Education Program.

[66]  A. Miccio,et al.  Gene Therapy for b-Hemoglobinopathies , 2022 .